JP2025143254A5 - - Google Patents
Info
- Publication number
- JP2025143254A5 JP2025143254A5 JP2025089886A JP2025089886A JP2025143254A5 JP 2025143254 A5 JP2025143254 A5 JP 2025143254A5 JP 2025089886 A JP2025089886 A JP 2025089886A JP 2025089886 A JP2025089886 A JP 2025089886A JP 2025143254 A5 JP2025143254 A5 JP 2025143254A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- cell
- pharmaceutically acceptable
- isotopically labeled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962931531P | 2019-11-06 | 2019-11-06 | |
| US62/931,531 | 2019-11-06 | ||
| JP2022526226A JP7690470B2 (ja) | 2019-11-06 | 2020-11-06 | がん幹細胞を標的化するがん治療 |
| PCT/US2020/059329 WO2021092322A1 (en) | 2019-11-06 | 2020-11-06 | Cancer treatments targeting cancer stem cells |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022526226A Division JP7690470B2 (ja) | 2019-11-06 | 2020-11-06 | がん幹細胞を標的化するがん治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025143254A JP2025143254A (ja) | 2025-10-01 |
| JP2025143254A5 true JP2025143254A5 (https=) | 2025-12-09 |
Family
ID=73643356
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022526226A Active JP7690470B2 (ja) | 2019-11-06 | 2020-11-06 | がん幹細胞を標的化するがん治療 |
| JP2025089886A Pending JP2025143254A (ja) | 2019-11-06 | 2025-05-29 | がん幹細胞を標的化するがん治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022526226A Active JP7690470B2 (ja) | 2019-11-06 | 2020-11-06 | がん幹細胞を標的化するがん治療 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP4055008A1 (https=) |
| JP (2) | JP7690470B2 (https=) |
| KR (1) | KR20220110744A (https=) |
| CN (2) | CN119930509A (https=) |
| AU (1) | AU2020378067A1 (https=) |
| BR (1) | BR112022008753A2 (https=) |
| CA (1) | CA3157315A1 (https=) |
| CO (1) | CO2022007910A2 (https=) |
| IL (1) | IL292718A (https=) |
| MX (1) | MX2022005445A (https=) |
| PH (1) | PH12022551081A1 (https=) |
| WO (1) | WO2021092322A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102831570B1 (ko) | 2018-05-04 | 2025-07-10 | 레미디 플랜, 인크. | 암 줄기 세포를 표적화하는 암 치료 |
| JP2024518089A (ja) * | 2021-05-13 | 2024-04-24 | リメディー プラン，インコーポレーテッド | Ｎａｍｐｔ阻害剤とその使用 |
| WO2024049225A1 (ko) | 2022-09-01 | 2024-03-07 | 주식회사 엘지에너지솔루션 | 이차 전지 및 이를 포함하는 디바이스 |
| CN116139141A (zh) * | 2022-12-14 | 2023-05-23 | 复旦大学 | Agk2促进肝癌的免疫治疗的用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19624659A1 (de) | 1996-06-20 | 1998-01-08 | Klinge Co Chem Pharm Fab | Neue Pyridylalken- und Pyridylalkinsäureamide |
| DE19624668A1 (de) | 1996-06-20 | 1998-02-19 | Klinge Co Chem Pharm Fab | Verwendung von Pyridylalkan-, Pyridylalken- bzw. Pyridylalkinsäureamiden |
| WO2008016643A2 (en) * | 2006-08-01 | 2008-02-07 | Cytokinetics, Incorporated | Certain chemical entities, compositions, and methods |
| WO2008026018A1 (en) | 2006-09-01 | 2008-03-06 | Topotarget Switzerland Sa | New method for the treatment of inflammatory diseases |
| FR2921657A1 (fr) * | 2007-09-28 | 2009-04-03 | Sanofi Aventis Sa | Derives de nicotinamide, leur preparation et leur application en therapeutique |
| EP2098231A1 (en) | 2008-03-05 | 2009-09-09 | Topotarget Switzerland SA | Use of NAD formation inhibitors for the treatment of ischemia-reperfusion injury |
| CA2877474A1 (en) * | 2011-06-20 | 2012-12-27 | Myrexis, Inc. | Compounds and therapeutic uses thereof |
| HK1211832A1 (zh) | 2012-05-07 | 2016-10-14 | The General Hospital Corporation | 用於癌症療法的抗高血壓藥物的新穎配方及用法 |
| ES2774330T3 (es) | 2013-04-09 | 2020-07-20 | Massachusetts Inst Technology | Polímero de suministro de fármaco y usos del mismo |
| TW201625641A (zh) * | 2014-05-22 | 2016-07-16 | 健臻公司 | Ｎａｍｐｔ抑制劑及方法 |
| US11078195B2 (en) * | 2016-03-17 | 2021-08-03 | Checkmate Therapeutics Inc. | Compound for inhibiting nicotinamide phosphoribosyltransferase and composition containing same |
| KR102831570B1 (ko) * | 2018-05-04 | 2025-07-10 | 레미디 플랜, 인크. | 암 줄기 세포를 표적화하는 암 치료 |
-
2020
- 2020-11-06 AU AU2020378067A patent/AU2020378067A1/en active Pending
- 2020-11-06 EP EP20816347.7A patent/EP4055008A1/en active Pending
- 2020-11-06 CA CA3157315A patent/CA3157315A1/en active Pending
- 2020-11-06 MX MX2022005445A patent/MX2022005445A/es unknown
- 2020-11-06 PH PH1/2022/551081A patent/PH12022551081A1/en unknown
- 2020-11-06 KR KR1020227018395A patent/KR20220110744A/ko active Pending
- 2020-11-06 JP JP2022526226A patent/JP7690470B2/ja active Active
- 2020-11-06 BR BR112022008753A patent/BR112022008753A2/pt unknown
- 2020-11-06 WO PCT/US2020/059329 patent/WO2021092322A1/en not_active Ceased
- 2020-11-06 CN CN202510009927.XA patent/CN119930509A/zh active Pending
- 2020-11-06 CN CN202080091217.1A patent/CN114929672B/zh active Active
-
2022
- 2022-05-03 IL IL292718A patent/IL292718A/en unknown
- 2022-06-03 CO CONC2022/0007910A patent/CO2022007910A2/es unknown
-
2025
- 2025-05-29 JP JP2025089886A patent/JP2025143254A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025143254A5 (https=) | ||
| CN117279916B (zh) | 含哌嗪结构的parp抑制剂、其制备方法及医药用途 | |
| DE60316542T2 (de) | 7-azaindole als inhibitoren c-jun n-terminaler kinasen zur behandlung neurodegenerativer störungen | |
| CN118434725B (zh) | 吡啶酰胺类parp抑制剂、及其制备方法和医药用途 | |
| EP4495113A1 (en) | Kif18a inhibitor | |
| RU2683566C1 (ru) | Производное с сочлененными кольцами и способ его получения, промежуточное соединение, фармацевтическая композиция и их применение | |
| CN108948004B (zh) | 作为fgfr4抑制剂的杂环化合物 | |
| JP2024529070A (ja) | Ａｔｒ阻害剤としてのナフチリジン誘導体およびその調製方法 | |
| CN105814041A (zh) | 用作tnf活性调节剂的苯并三唑衍生物 | |
| WO2022121981A1 (zh) | 新型喜树碱衍生物、含其的组合物和其用途 | |
| CN115702155B (zh) | 新型吡啶并[2,3-d]嘧啶-7(8H)-酮衍生物 | |
| JP2017510657A (ja) | Ｍｉｆ阻害剤 | |
| JP2025526425A (ja) | 抗体薬物複合体に適した毒素分子 | |
| JP2026041824A (ja) | テガビビントの結晶形態、調製方法、及びその使用 | |
| WO2022033552A1 (zh) | Cdk激酶抑制剂、其制备方法、药物组合物和应用 | |
| JPWO2021092322A5 (https=) | ||
| CN120051467A (zh) | 2(1h)-吡啶亚胺衍生物 | |
| JP2023505238A (ja) | 新規ピロール化合物 | |
| JP5378499B2 (ja) | 微小管形成阻害剤として有用なベンゾフェノンチアゾール誘導体及びその製造方法 | |
| CN115135646B (zh) | 取代的多环化合物及其药物组合物和用途 | |
| WO2016187028A1 (en) | Heteroaryl compounds, synthesis thereof, and intermediates thereto | |
| CN107973764B (zh) | 穿心莲内酯类化合物、其制备方法、药物组合物及应用 | |
| CA3123995C (en) | Phenylpyrrolidine compound and use thereof | |
| CN118359632A (zh) | 喜树碱衍生物、其制备方法及其用途 | |
| CN113831323B (zh) | 芳杂环酰胺类化合物及其用途 |